Viewing Study NCT02979535


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2025-12-25 @ 8:05 PM
Study NCT ID: NCT02979535
Status: COMPLETED
Last Update Posted: 2022-03-25
First Post: 2016-11-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization: